Havasu leans into the hair-loss niche: the label sells a DHT blocker for men, hair and prostate support, the whole pitch. Under the marketing is 500 mg of unstandardized saw palmetto berry per serving - no fatty-acid standardization, no published COA - and hair-growth claims that ride on a handful of small, preliminary studies. Saw palmetto does act on the 5-alpha-reductase/DHT pathway, but far more weakly than finasteride, and the human hair evidence is thin. This is the clearest example on the list of claims outrunning substantiation.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Saw Palmetto guide →Unstandardized whole-berry capsule with no fatty-acid/sterol specification, despite prominent DHT-blocker marketing. Form is the weakest link here.
500 mg per serving of unstandardized berry cannot be equated to the 320 mg liposterolic extract dose used in trials.
Non-GMO and vegan, but no prominently published independent COA to back the hair/DHT positioning.
Generally well tolerated as a berry capsule; the main risk is disappointment against overstated hair claims, not physical harm.
100 capsules for ~$14-18 is average; you are partly paying for the DHT-blocker branding rather than a superior extract.
“Blocks DHT to stop hair loss”
Saw palmetto weakly inhibits 5-alpha-reductase, but human hair-loss evidence is limited to small preliminary studies (Prager 2002; Rossi 2012). It is not an established DHT blocker for hair on par with finasteride.
“Provides prostate and urinary support”
Saw palmetto is traditionally used for BPH, but the largest rigorous trials (Bent 2006, Barry 2011) found no benefit over placebo, so support claims are contested.
“500 mg delivers a clinically meaningful saw palmetto dose”
Unstandardized 500 mg berry is not equivalent to the 320 mg standardized liposterolic extract used in the trials.
The DHT-blocker, hair-vitamin framing is the product's main feature. The actual contents - unstandardized 500 mg berry with no published COA - are less impressive than the label implies. When the claim is louder than the substantiation, that is the tell.
The few human trials of saw palmetto for androgenetic alopecia (Prager 2002; Rossi 2012) are small and preliminary and show far weaker effects than finasteride. Buying this expecting reliable regrowth is buying the marketing, not the data.
Havasu is the product where marketing most outruns substance. It is sold as a DHT-blocking hair vitamin, but inside is unstandardized 500 mg berry with no published testing and hair claims built on a few small, preliminary studies. Saw palmetto's DHT effect is real but weak, and there is no reason to pay for the branding. If you want to trial saw palmetto honestly, a standardized 320 mg extract is the better buy.
Check Havasu Nutrition on AmazonIf the DHT pathway is your interest, this pairs CO2 liposterolic extract with beta-sitosterol - the mechanistically serious version.
See it on the list →Standardized clinical-dose extract, no hype, far better value.
See it on the list →A small pilot trial reported modest hair improvement with a saw palmetto-based formula, but the sample was tiny and preliminary - not proof of reliable regrowth.
Saw palmetto produced far smaller hair improvements than finasteride, confirming its DHT effect is weak relative to the pharmaceutical standard.
